In particular, one study demonstrated an improved anti-tumor effect of an HPMA-linear peptide conjugate targeting mouse PD-L1 compared to the free peptide in syngeneic BALB/c mice bearing 4T1 tumors (27). Here, CD274 is linked to neoplasm.